Oviva was founded in 2014 by a multidisciplinary team of health and technology experts. Half of the European population is overweight and at a higher risk of developing type 2 diabetes. The three founders Kai Eberhardt (CEO), Manuel Baumann (CTO) and Mark Jenkins (UK Managing & Medical Director) recognised that, despite this, there were no personalised, long-term treatment options. Their solution was to combine personal advice by a dietitian with a smart app that patients use to record relevant information such as meals, physical activity or weight and also provides them with learning content. In addition, the app's chat feature enables a regular exchange with the nutritionist and provides the patient with helpful learning content.

Longer term, Oviva helps its patients to lead a healthier life, relieves pressure on doctors to advise on weight and lifestyle, and ultimately leads to savings for the health system. Oviva works directly with statutory health insurers and national health systems and operates in Switzerland, Germany, the UK and France. The Oviva App has been certified as a medical device since January 2021.

Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.

Novo Nordisk is a leader in obesity care, helping advance the understanding and management of obesity as a chronic disease. Changing Obesity™ is Novo Nordisk’s long-term commitment to – together with our partners – improve the lives of people with obesity, by changing how the world sees, prevents and treats obesity.

Headquartered in Denmark, Novo Nordisk employs approximately 43,200 employees in 80 countries and markets its products in more than 170 countries.

Contact	: Jakob Jakobsen
W	: www.novonordisk.com
P	: +45 3079 0781
E	: [email protected]

Herbalife Nutrition is a global company committed to addressing the worldwide problems of poor nutrition, obesity, an aging population, and sky-rocketing healthcare costs since 1980. The company offers high-quality, science-backed products, sold in over 90 countries by entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle. Through the company’s global campaign to eradicate hunger, Herbalife Nutrition is also committed to bringing nutrition and education to communities around the world.

For more information, please visit IAmHerbalifeNutrition.com.

International Medical Press (IMP) specializes in providing independent and accredited medical education activities funded through unrestricted educational grants. IMP has extensive experience in medical education, is backed by enduring relationships with faculty and provides strong scientific support across several therapy areas.

IMP is a founding partner of the Good CME Practice (gCMEp) Group that is committed to delivering patient-centred, balanced and effective medical education.

PronoKal Group® is a multinational company specialising in medical weight loss and weight control treatments based on comprehensive programmes involving a team of healthcare professionals (doctors, dieticians-nutritionists, physical trainers and coaches).

PronoKal Group® has a wealth of experience in the weight loss sector and operates on an international level in Europe and America.

PronoKal Group® began its activities in 2004 with the launch of the PronoKal® Method in Spain. Since 2009, the expansion and internationalisation has been consolidated: PronoKal Group® is currently in more than 15 countries.

The success of our medical treatment is backed by more than 600,000 patients treated and more than 8,000 prescribing doctors who trust in the rigour and effectiveness of our methods. These figures position Pronokal Group® as a leading company in the weight management sector.

Contact	: Ivan Benavent
W	: www.pronokalgroup.com
P	: +34 931 833 300 / +34 687 160 069
E	: [email protected]